Adverse ophthalmic reactions associated with poppers use

Article

Users of poppers have experienced visual impairment and maculopathy in a UK case series

Though poppers have been considered by scientific experts to present a low risk to physical and mental health, there have been reports of 'poppers maculopathy' since 2007, when (due to legislative changes) the most commonly used compound in poppers was changed from isobutyl nitrite to isopropyl nitrite.

Clinical issues observed

Of the seven patients included in the series, two had used poppers regularly over a period of 20 and 14 years and had begun to notice visual impairment over the preceding two years, while the remaining five patients each reported taking the substances for the first or only time within the previous two weeks. The habitual poppers users took longer to diagnose (median: 16 months) and presented with more severe initial symptoms compared with first- or one-time users.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.